NECMF

Mar 21, 2016 10:37 AM

FDA approves new injection to combat anthrax

The Associated Press

WASHINGTON (AP) Federal health officials have approved a new injectable drug to treat patients who have been exposed to the deadly toxin anthrax.

The Food and Drug Administration said it approved Anthim on Friday to treat inhalation anthrax, which can cause serious injury and death. The condition occurs when anthrax bacterial spores are inhaled.

Because anthrax is a potential bioterrorism weapon the U.S. government has been funding the development and production of therapies.

Anthim was developed by Elusys Therapeutics Inc. of Pine Brook, New Jersey, with support from the Biomedical Advanced Research and Development Authority. The government agency stockpiles vaccines, drugs and equipment for use during pandemics and other health emergencies.

--  Need a new car or even a boat? Click here to check out the all-new NH1 Motors --

--

»Comments

Must Read on NH1.com

NH1 Dining

NH1 on Facebook

NH1 on Twitter